Key result
A high burden of both microvascular and macrovascular abnormalities was associated with a shorter total life expectancy (6.95 vs 8.71 years; p<0.001) compared to a low burden.
Why the study?
Does a high burden of microvascular and macrovascular abnormalities reduce total and disability-free life expectancy in older adults?
Cohort (n=2,452)
Does a high burden of microvascular and macrovascular abnormalities reduce total and disability-free life expectancy in older adults?
Absolute Event Rate: 6.95% vs 8.71%
p-value: p=<.001
A high burden of both microvascular and macrovascular abnormalities significantly reduces total and disability-free life expectancy in older adults.
No takes yet. Share an insight, caveat, or question.
May aid vascular risk stratification in older adults without changing management; leaves open causal effects on longevity.
Kim et al. (2014) conducted a cohort in Microvascular and macrovascular abnormalities (n=2,452). High burden of microvascular and macrovascular abnormalities vs. Low burden of both abnormalities was evaluated on Total life expectancy (p=<.001). A high burden of both microvascular and macrovascular abnormalities was associated with a shorter total life expectancy (6.95 vs 8.71 years; p<0.001) compared to a low burden.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: